Kazia Therapeutics (KZIA) Revenue (2016)

Kazia Therapeutics' (KZIA) quarterly Revenue came in at $107463.9 in Q4 2016.

Kazia Therapeutics (KZIA) Revenue (2016) Analysis & Trends

Kazia Therapeutics (KZIA) has 1 years of Revenue data on file, last reported at $107463.9 in Q4 2016.

Quarterly Revenue changed N/A year-over-year to $107463.9 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $15.0 million (changed N/A YoY) and the FY2025 annual result came in at $26898.2, down 98.23% from the prior year.
Revenue was little changed at $107463.9 in Q4 2016.
In the past five years, Revenue ranged from a high of $107463.9 in Q4 2016 to a low of $107463.9 in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1.56 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.71 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	3,001.92
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	674.14 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	1.29 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	425.49 Mn
10	Kazia Therapeutics	4.22 Bn	4.22 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2016	107,463.94